Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New approach aims to cut donor blood use in cancer operations

NCT ID NCT04922307

Summary

This study tests whether using a patient's own blood during kidney cancer surgery can reduce the need for donor blood transfusions. Researchers are comparing standard blood management against techniques that recycle or dilute the patient's blood during the operation. The goal is to lower transfusion-related risks and potentially improve recovery outcomes for 240 patients with advanced kidney cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • H. Lee Moffitt Cancer Center

    Tampa, Florida, 33612, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

  • Winship Cancer Institute at Emory University

    Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.